Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9988865 | European Journal of Paediatric Neurology | 2005 | 7 Pages |
Abstract
In ambulant patients with DMD, we found that muscle function assessed by timed functional tests (running 9Â m and rising up from the floor) and muscle force assessed by hand-held dynamometry were severely impaired. However, a small reduction of muscle force was accompanied by a large reduction in functional ability. Therefore, in our group of ambulant patients with DMD, timed functional testing was the most sensitive parameter to determine the extent of disease progression. Timed functional testing may therefore be considered as an additional outcome measure in drug trials to evaluate the effects of therapy in ambulant patients with DMD and possibly in other neuromuscular disorders.
Related Topics
Life Sciences
Neuroscience
Developmental Neuroscience
Authors
Ernesto A.C. Beenakker, Natalia M. Maurits, Johanna M. Fock, Oebele F. Brouwer, Johannes H. van der Hoeven,